Ankündigung • Jun 30
Guangdong Guanghua Sci-Tech Co., Ltd. to Report First Half, 2026 Results on Aug 29, 2026 Guangdong Guanghua Sci-Tech Co., Ltd. announced that they will report first half, 2026 results on Aug 29, 2026 New Risk • May 26
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 27% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (8.2% average weekly change). Large one-off items impacting financial results. Upcoming Dividend • May 05
Upcoming dividend of CN¥0.10 per share Eligible shareholders must have bought the stock before 12 May 2026. Payment date: 12 May 2026. Payout ratio is a comfortable 39% but the company is not cash flow positive. Trailing yield: 0.5%. Lower than top quartile of Chinese dividend payers (1.9%). Lower than average of industry peers (1.2%). New Risk • Apr 15
New minor risk - Dividend sustainability The dividend is not well covered by cash flows. The company is paying a dividend despite having no free cash flows. Dividend yield: 0.5% This is considered a minor risk. Dividends are ultimately paid out of the company's available cash reserves. Companies that pay out too much of their cash flow are at risk of having to reduce or cut their dividend in future. If cash flow growth slows or cash flows fall, then there may not be enough cash reserves to maintain the same dividend. Or in extreme cases, companies may opt to take on debt to maintain the dividend. This risk is mitigated by the fact the dividend is covered by earnings, however, cash flows are generally more important. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 27% per year over the past 5 years. Minor Risks Paying a dividend despite having no free cash flows. Large one-off items impacting financial results. Ankündigung • Mar 31
Guangdong Guanghua Sci-Tech Co., Ltd. to Report Q1, 2026 Results on Apr 30, 2026 Guangdong Guanghua Sci-Tech Co., Ltd. announced that they will report Q1, 2026 results on Apr 30, 2026 Reported Earnings • Mar 31
Full year 2025 earnings released: EPS: CN¥0.22 (vs CN¥0.51 loss in FY 2024) Full year 2025 results: EPS: CN¥0.22 (up from CN¥0.51 loss in FY 2024). Revenue: CN¥2.96b (up 14% from FY 2024). Net income: CN¥103.9m (up CN¥308.9m from FY 2024). Profit margin: 3.5% (up from net loss in FY 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings. Ankündigung • Mar 31
Guangdong Guanghua Sci-Tech Co., Ltd., Annual General Meeting, Apr 23, 2026 Guangdong Guanghua Sci-Tech Co., Ltd., Annual General Meeting, Apr 23, 2026, at 14:30 China Standard Time. Location: 5F, No. 295, Daxue Road, Shantou, Guangdong China New Risk • Feb 28
New major risk - Revenue and earnings growth Earnings have declined by 49% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. This is currently the only risk that has been identified for the company. Ankündigung • Dec 31
Guangdong Guanghua Sci-Tech Co., Ltd. to Report Fiscal Year 2025 Results on Apr 28, 2026 Guangdong Guanghua Sci-Tech Co., Ltd. announced that they will report fiscal year 2025 results on Apr 28, 2026 New Risk • Nov 28
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company. Reported Earnings • Oct 16
Third quarter 2025 earnings released: EPS: CN¥0.073 (vs CN¥0.01 loss in 3Q 2024) Third quarter 2025 results: EPS: CN¥0.073 (up from CN¥0.01 loss in 3Q 2024). Revenue: CN¥762.3m (up 15% from 3Q 2024). Net income: CN¥34.1m (up CN¥38.1m from 3Q 2024). Profit margin: 4.5% (up from net loss in 3Q 2024). Revenue is forecast to grow 21% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 29% per year but the company’s share price has increased by 6% per year, which means it is well ahead of earnings. Ankündigung • Sep 30
Guangdong Guanghua Sci-Tech Co., Ltd. to Report Q3, 2025 Results on Oct 27, 2025 Guangdong Guanghua Sci-Tech Co., Ltd. announced that they will report Q3, 2025 results on Oct 27, 2025 Ankündigung • Sep 04
Guangdong Guanghua Sci-Tech Co., Ltd. Approves Board Elections Guangdong Guanghua Sci-Tech Co., Ltd. its 1st Extraordinary General Meeting of 2025 on 02 September 2025 approved the election of Yan Yonghong, independent director and Xu Tao, independent director. New Risk • Jul 29
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (6.6% average weekly change). Shareholders have been diluted in the past year (16% increase in shares outstanding). Ankündigung • Jul 02
Guangdong Guanghua Sci-Tech Co., Ltd. to Report First Half, 2025 Results on Aug 30, 2025 Guangdong Guanghua Sci-Tech Co., Ltd. announced that they will report first half, 2025 results on Aug 30, 2025 Ankündigung • Apr 24
Guangdong Guanghua Sci-Tech Co., Ltd., Annual General Meeting, May 15, 2025 Guangdong Guanghua Sci-Tech Co., Ltd., Annual General Meeting, May 15, 2025, at 14:30 China Standard Time. Location: 5F, No. 295, Daxue Road, Shantou, Guangdong China Reported Earnings • Apr 16
Full year 2024 earnings released: CN¥0.51 loss per share (vs CN¥1.08 loss in FY 2023) Full year 2024 results: CN¥0.51 loss per share (improved from CN¥1.08 loss in FY 2023). Revenue: CN¥2.59b (down 4.1% from FY 2023). Net loss: CN¥204.9m (loss narrowed 52% from FY 2023). Revenue is forecast to grow 37% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 76 percentage points per year, which is a significant difference in performance. Ankündigung • Mar 31
Guangdong Guanghua Sci-Tech Co., Ltd. to Report Q1, 2025 Results on Apr 30, 2025 Guangdong Guanghua Sci-Tech Co., Ltd. announced that they will report Q1, 2025 results on Apr 30, 2025 Ankündigung • Dec 31
Guangdong Guanghua Sci-Tech Co., Ltd. to Report Fiscal Year 2024 Results on Apr 26, 2025 Guangdong Guanghua Sci-Tech Co., Ltd. announced that they will report fiscal year 2024 results on Apr 26, 2025 New Risk • Nov 29
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 11% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (0.8% operating cash flow to total debt). Minor Risks Share price has been volatile over the past 3 months (11% average weekly change). Shareholders have been diluted in the past year (17% increase in shares outstanding). New Risk • Nov 16
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 17% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (0.8% operating cash flow to total debt). Minor Risk Shareholders have been diluted in the past year (17% increase in shares outstanding). Board Change • Nov 12
Less than half of directors are independent Following the recent departure of a director, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 5 non-independent directors. Independent Director Zhen Feng Liang was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Oct 31
Third quarter 2024 earnings released: CN¥0.01 loss per share (vs CN¥0.27 loss in 3Q 2023) Third quarter 2024 results: CN¥0.01 loss per share (improved from CN¥0.27 loss in 3Q 2023). Revenue: CN¥663.0m (down 7.5% from 3Q 2023). Net loss: CN¥3.96m (loss narrowed 96% from 3Q 2023). Revenue is forecast to grow 31% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 70 percentage points per year, which is a significant difference in performance. Ankündigung • Sep 30
Guangdong Guanghua Sci-Tech Co., Ltd. to Report Q3, 2024 Results on Oct 31, 2024 Guangdong Guanghua Sci-Tech Co., Ltd. announced that they will report Q3, 2024 results on Oct 31, 2024 Reported Earnings • Aug 26
Second quarter 2024 earnings released: EPS: CN¥0.017 (vs CN¥0.069 loss in 2Q 2023) Second quarter 2024 results: EPS: CN¥0.017 (up from CN¥0.069 loss in 2Q 2023). Revenue: CN¥658.5m (up 7.8% from 2Q 2023). Net income: CN¥6.94m (up CN¥34.5m from 2Q 2023). Profit margin: 1.1% (up from net loss in 2Q 2023). Revenue is forecast to grow 29% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 66 percentage points per year, which is a significant difference in performance. Ankündigung • Jun 29
Guangdong Guanghua Sci-Tech Co., Ltd. to Report First Half, 2024 Results on Aug 31, 2024 Guangdong Guanghua Sci-Tech Co., Ltd. announced that they will report first half, 2024 results on Aug 31, 2024 New Risk • May 27
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (19% operating cash flow to total debt). Minor Risk Share price has been volatile over the past 3 months (8.8% average weekly change). New Risk • May 22
New major risk - Financial position The company's debt is not well covered by operating cash flow. Operating cash flow to total debt ratio: 19% This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. This is currently the only risk that has been identified for the company. Price Target Changed • May 14
Price target decreased by 11% to CN¥14.09 Down from CN¥15.86, the current price target is an average from 2 analysts. New target price is 32% above last closing price of CN¥10.68. Stock is down 36% over the past year. The company is forecast to post earnings per share of CN¥0.16 for next year compared to CN¥0.30 last year. Ankündigung • Apr 29
Guangdong Guanghua Sci-Tech Co., Ltd., Annual General Meeting, May 17, 2024 Guangdong Guanghua Sci-Tech Co., Ltd., Annual General Meeting, May 17, 2024, at 14:30 China Standard Time. Location: The Company's Meeting Room, Shantou, Guangdong China Ankündigung • Mar 30
Guangdong Guanghua Sci-Tech Co., Ltd. to Report Q1, 2024 Results on Apr 30, 2024 Guangdong Guanghua Sci-Tech Co., Ltd. announced that they will report Q1, 2024 results on Apr 30, 2024 Ankündigung • Dec 30
Guangdong Guanghua Sci-Tech Co., Ltd. to Report Fiscal Year 2023 Results on Apr 27, 2024 Guangdong Guanghua Sci-Tech Co., Ltd. announced that they will report fiscal year 2023 results on Apr 27, 2024 Reported Earnings • Nov 01
Third quarter 2023 earnings released: CN¥0.16 loss per share (vs CN¥0.062 profit in 3Q 2022) Third quarter 2023 results: CN¥0.16 loss per share (down from CN¥0.062 profit in 3Q 2022). Revenue: CN¥733.1m (down 20% from 3Q 2022). Net loss: CN¥63.7m (down 361% from profit in 3Q 2022). Revenue is forecast to grow 31% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 70 percentage points per year, which is a significant difference in performance. Price Target Changed • Oct 18
Price target decreased by 20% to CN¥15.86 Down from CN¥19.88, the current price target is provided by 1 analyst. New target price is 17% above last closing price of CN¥13.55. Stock is down 28% over the past year. The company is forecast to post earnings per share of CN¥0.16 for next year compared to CN¥0.30 last year. Ankündigung • Sep 30
Guangdong Guanghua Sci-Tech Co., Ltd. to Report Q3, 2023 Results on Oct 31, 2023 Guangdong Guanghua Sci-Tech Co., Ltd. announced that they will report Q3, 2023 results on Oct 31, 2023 Board Change • Sep 22
Less than half of directors are independent Following the recent departure of a director, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 5 non-independent directors. Independent Director Zhen Feng Liang was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Aug 31
Second quarter 2023 earnings released: CN¥0.069 loss per share (vs CN¥0.12 profit in 2Q 2022) Second quarter 2023 results: CN¥0.069 loss per share (down from CN¥0.12 profit in 2Q 2022). Revenue: CN¥610.9m (down 39% from 2Q 2022). Net loss: CN¥27.6m (down 158% from profit in 2Q 2022). Revenue is forecast to grow 32% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 30% per year but the company’s share price has increased by 4% per year, which means it is well ahead of earnings. Reported Earnings • Mar 08
Full year 2022 earnings: EPS and revenues miss analyst expectations Full year 2022 results: EPS: CN¥0.30 (up from CN¥0.16 in FY 2021). Revenue: CN¥3.30b (up 28% from FY 2021). Net income: CN¥116.9m (up 88% from FY 2021). Profit margin: 3.5% (up from 2.4% in FY 2021). Revenue missed analyst estimates by 1.1%. Earnings per share (EPS) also missed analyst estimates by 24%. Revenue is forecast to grow 26% p.a. on average during the next 2 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 75% per year but the company’s share price has only increased by 21% per year, which means it is significantly lagging earnings growth. Price Target Changed • Nov 16
Price target decreased to CN¥19.88 Down from CN¥23.85, the current price target is provided by 1 analyst. New target price is approximately in line with last closing price of CN¥20.64. Stock is down 9.6% over the past year. The company is forecast to post earnings per share of CN¥0.38 for next year compared to CN¥0.16 last year. Board Change • Nov 16
Less than half of directors are independent Following the recent departure of a director, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 5 non-independent directors. Independent Director Zhen Feng Liang was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Valuation Update With 7 Day Price Move • Nov 07
Investor sentiment improved over the past week After last week's 18% share price gain to CN¥20.49, the stock trades at a forward P/E ratio of 33x. Average forward P/E is 15x in the Chemicals industry in China. Total returns to shareholders of 80% over the past three years. Reported Earnings • Oct 30
Third quarter 2022 earnings released: EPS: CN¥0.062 (vs CN¥0.051 in 3Q 2021) Third quarter 2022 results: EPS: CN¥0.062 (up from CN¥0.051 in 3Q 2021). Revenue: CN¥914.5m (up 34% from 3Q 2021). Net income: CN¥24.4m (up 29% from 3Q 2021). Profit margin: 2.7% (down from 2.8% in 3Q 2021). Revenue is forecast to grow 21% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 70% per year but the company’s share price has only increased by 16% per year, which means it is significantly lagging earnings growth. Board Change • Oct 02
High number of new directors There are 5 new directors who have joined the board in the last 3 years. Independent Director Zhen Feng Liang was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Ankündigung • Sep 07
Guangdong Guanghua Sci-Tech Co., Ltd. Approves Board Appointments Guangdong Guanghua Sci-Tech Co., Ltd. announced at the EGM held on September 2, 2022 that the company approved election of Zhuang Shengjia as non-independent director; Peng Chaohui, Liang Zhenfeng and Chen Mingcai as independent directors. Reported Earnings • Aug 26
Second quarter 2022 earnings released: EPS: CN¥0.12 (vs CN¥0.049 in 2Q 2021) Second quarter 2022 results: EPS: CN¥0.12 (up from CN¥0.049 in 2Q 2021). Revenue: CN¥1.01b (up 58% from 2Q 2021). Net income: CN¥47.2m (up 142% from 2Q 2021). Profit margin: 4.7% (up from 3.1% in 2Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 50% per year but the company’s share price has only increased by 26% per year, which means it is significantly lagging earnings growth. Ankündigung • Jun 03
Guangdong Guanghua Sci-Tech Co., Ltd. Announces Final Dividend on A Shares for the Year 2021, Payable on June 10, 2022 Guangdong Guanghua Sci-Tech Co., Ltd. announced final cash dividend/10 shares (tax included) of CNY 0.30000000 on A shares for the year 2021. Record date is June 9, 2022. Ex-date is June 10, 2022. Payment date is June 10, 2022. Ankündigung • May 15
Guangdong Guanghua Sci-Tech Co., Ltd. Approves Cash Dividend for 2021 Guangdong Guanghua Sci-Tech Co., Ltd. at its annual general meeting held on 12 May 2022 approved Cash dividend of CNY 0.30000000 per 10 shares for 2021. Board Change • Apr 27
Less than half of directors are independent Following the recent departure of a director, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 5 non-independent directors. Independent Director Yuping Wu was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Ankündigung • Apr 24
Guangdong Guanghua Sci-Tech Co., Ltd., Annual General Meeting, May 12, 2022 Guangdong Guanghua Sci-Tech Co., Ltd., Annual General Meeting, May 12, 2022, at 14:30 China Standard Time. Agenda: To consider 2021 annual report and its summary; to consider 2021 work report of the board of directors; to consider 2021 work report of the supervisory committee; to consider 2021 annual accounts; to consider 2021 profit distribution plan; to consider Remuneration for directors in 2021 and 2022; and to transact other matters. Ankündigung • Apr 22
Guangdong Guanghua Sci-Tech Co., Ltd. Proposes Dividend for 2021 Guangdong Guanghua Sci-Tech Co., Ltd. proposed Cash dividend/10 shares (tax included) of CNY 0.30000000 for 2021. Reported Earnings • Apr 21
First quarter 2022 earnings: EPS and revenues miss analyst expectations First quarter 2022 results: EPS: CN¥0.09 (up from CN¥0.03 in 1Q 2021). Revenue: CN¥760.2m (up 45% from 1Q 2021). Net income: CN¥35.3m (up 234% from 1Q 2021). Profit margin: 4.6% (up from 2.0% in 1Q 2021). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 7.7%. Earnings per share (EPS) also missed analyst estimates by 77%. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth. Reported Earnings • Oct 31
Third quarter 2021 earnings released: EPS CN¥0.051 (vs CN¥0.028 in 3Q 2020) The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥683.2m (up 36% from 3Q 2020). Net income: CN¥18.9m (up 79% from 3Q 2020). Profit margin: 2.8% (up from 2.1% in 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 49% per year but the company’s share price has increased by 15% per year, which means it is well ahead of earnings. Reported Earnings • Aug 31
Second quarter 2021 earnings released: EPS CN¥0.049 (vs CN¥0.064 in 2Q 2020) The company reported a soft second quarter result with weaker earnings and profit margins, although revenues improved. Second quarter 2021 results: Revenue: CN¥635.8m (up 3.9% from 2Q 2020). Net income: CN¥19.5m (down 20% from 2Q 2020). Profit margin: 3.1% (down from 4.0% in 2Q 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 84 percentage points per year, which is a significant difference in performance. Reported Earnings • Apr 17
Full year 2020 earnings released: EPS CN¥0.10 (vs CN¥0.04 in FY 2019) The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥2.01b (up 18% from FY 2019). Net income: CN¥36.6m (up 171% from FY 2019). Profit margin: 1.8% (up from 0.8% in FY 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 60 percentage points per year, which is a significant difference in performance. Is New 90 Day High Low • Feb 26
New 90-day high: CN¥13.98 The company is up 6.0% from its price of CN¥13.19 on 27 November 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 15% over the same period. Is New 90 Day High Low • Dec 16
New 90-day low: CN¥12.32 The company is down 17% from its price of CN¥14.80 on 17 September 2020. The Chinese market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 6.0% over the same period. Is New 90 Day High Low • Nov 26
New 90-day low: CN¥12.97 The company is down 6.0% from its price of CN¥13.75 on 28 August 2020. The Chinese market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 8.0% over the same period. Is New 90 Day High Low • Oct 30
New 90-day low: CN¥13.21 The company is down 3.0% from its price of CN¥13.55 on 31 July 2020. The Chinese market is down 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 2.0% over the same period. Reported Earnings • Oct 26
Third quarter earnings released Over the last 12 months the company has reported total profits of CN¥706.8k, down 98% from the prior year. Total revenue was CN¥1.87b over the last 12 months, up 19% from the prior year. Ankündigung • Oct 19
Guangdong Guanghua Sci-Tech Co., Ltd. to Report Q3, 2020 Results on Oct 26, 2020 Guangdong Guanghua Sci-Tech Co., Ltd. announced that they will report Q3, 2020 results on Oct 26, 2020 Is New 90 Day High Low • Oct 12
New 90-day high: CN¥15.26 The company is up 17% from its price of CN¥13.04 on 14 July 2020. The Chinese market is down 6.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 2.0% over the same period. Ankündigung • Aug 12
Guangdong Guanghua Sci-Tech Co., Ltd. to Report First Half, 2020 Results on Aug 28, 2020 Guangdong Guanghua Sci-Tech Co., Ltd. announced that they will report first half, 2020 results on Aug 28, 2020